FLT3 and acute myeloid leukemia: 3.2. Several Metabolic Inhibitors Have Antiproliferative Effects on Primary AML Cells, with no Association with Secondary AML, AML cell Differentiation, Karyotype, FLT3 or NPM1 Mutations, or Patient Survival